Literature DB >> 14975703

Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells.

Ken Shimamura1, Yuko Takashiro, Nobuteru Akiyama, Tetsuya Hirabayashi, Toshihiko Murayama.   

Abstract

We investigated the effects of sphingosine 1-phosphate and histamine on the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and E-selectin, and their signaling pathways in human umbilical vein endothelial cells. Sphingosine 1-phosphate increased the mRNA and protein level of VCAM-1, and the mRNAs of E-selectin and ICAM-1. The effects of sphingosine 1-phosphate were inhibited by the pertussis toxin and the respective inhibitors (10 microM 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) for phosphoinositide-specific phospholipase C; 10 microM 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580) for p38 mitogen-activated protein kinase (MAPK); 1 microM 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole (Gö6976) for the alpha form of protein kinase C (PKC-alpha)), but not by a PKC-delta inhibitor (1 microM rottlerin). Histamine, which alone showed no effect, enhanced the sphingosine 1-phosphate-induced expressions via histamine H(1) receptor. The histamine response decreased by U73122 and rottlerin, but not by SB203580 and Gö6976. The effects of sphingosine 1-phosphate with and without histamine were abolished by the higher concentrations of PKC inhibitors and in the PKC-depleted cells. Sphingosine 1-phosphate and histamine alone stimulated phosphorylation of p38 MAPK in a phosphoinositide-specific phospholipase C-dependent but not in a PKCs-independent manner. These findings suggest that sphingosine 1-phosphate-induced expression of adhesion molecules was mediated by phosphoinositide-specific phospholipase C and preferentially by PKC-alpha and p38 MAPK, and the histamine response was mediated by phosphoinositide-specific phospholipase C and PKC-delta in human umbilical vein endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975703     DOI: 10.1016/j.ejphar.2003.12.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration.

Authors:  Arshad Rahman; Fabeha Fazal
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

2.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 3.  Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.

Authors:  Mirjam Schuchardt; Markus Tölle; Jasmin Prüfer; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration.

Authors:  Yoshikazu Ono; Makoto Kurano; Ryunosuke Ohkawa; Hiromitsu Yokota; Koji Igarashi; Junken Aoki; Minoru Tozuka; Yutaka Yatomi
Journal:  Lipids Health Dis       Date:  2013-02-18       Impact factor: 3.876

5.  A prokaryotic S1P lyase degrades extracellular S1P in vitro and in vivo: implication for treating hyperproliferative disorders.

Authors:  Andrea Huwiler; Florence Bourquin; Nataliya Kotelevets; Oleksandr Pastukhov; Guido Capitani; Markus G Grütter; Uwe Zangemeister-Wittke
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

6.  Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.

Authors:  Amanda Finley; Zhoumou Chen; Emanuela Esposito; Salvatore Cuzzocrea; Roger Sabbadini; Daniela Salvemini
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

7.  Sphingolipids: a potential molecular approach to treat allergic inflammation.

Authors:  Wai Y Sun; Claudine S Bonder
Journal:  J Allergy (Cairo)       Date:  2012-12-18

8.  Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury.

Authors:  Ahrom Ham; Mihwa Kim; Joo Yun Kim; Kevin M Brown; Marcus Fruttiger; Vivette D D'Agati; H Thomas Lee
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.